Arslanian, S.* et al. Effect of semaglutide on insulin sensitivity and cardiometabolic risk factors in adolescents with obesity: The STEP TEENS study. Diabetes Care:dc250824 (2025)
Barovic, M.* et al. Proteomic and metabolomic signatures in prediabetes progressing to diabetes or reversing to normoglycemia within 1 Year. Diabetes Care 48, 405-415 (2025)
Ge, J. et al. Integrative metabolomics of targeted and non-targeted analyses in T2D progression. Diabetes Care:dc251707 (2025)
Köger, M. et al. Generalizability of progression risk in the TN-10 trial to a European 
population with or  without a first-degree relative with type 1 diabetes. Diabetes Care, DOI: 10.2337/dc25-1021 (2025)
Koskenniemi, J.J.* et al. The contribution of BMI to a young child's risk of islet autoimmunity is dependent on HLA-DR4-DQ8 without HLA-DR3-DQ2. Diabetes Care 48, 2103-2110 (2025)
Mantovani, A.* et al. Sodium-glucose cotransporter 2 inhibitor use and risk of liver-related events in patients with type 2 diabetes: A meta-analysis of observational cohort studies. Diabetes Care 48, 1042-1052 (2025)
Rewers, M.* et al. Unfolding the mystery of autoimmunity: The environmental determinants of diabetes in the young (TEDDY) study. Diabetes Care 48, 1125-1135 (2025)
Sandforth, L. et al. Subphenotype-dependent benefits of bariatric surgery for individuals at risk for type 2 diabetes. Diabetes Care 48, 996-1006 (2025)
Wagner, R. et al. Beyond glucose-rethinking prediabetes for precision prevention. Diabetes Care, DOI: 10.2337/dci25-0054 (2025)
Ebert, T.* et al. Outcomes with finerenone in patients with chronic kidney disease and type 2 diabetes by baseline insulin resistance. Diabetes Care 47, 362-370 (2024)
Ghalwash, M.* et al. Data-driven phenotyping of presymptomatic type 1 diabetes using longitudinal autoantibody profiles. Diabetes Care 47, 1424-1431 (2024)
Hammersen, J.* et al. Clinical outcomes in pediatric patients with type 1 diabetes with early versus late diagnosis: Analysis from the DPV registry. Diabetes Care 47, 1808-1817 (2024)
Phillip, M.* et al. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care 47, 1276-1298 (2024)
von Rauchhaupt, E.* et al. Glucose load following prolonged fasting increases oxidative stress-linked response in individuals with diabetic complications. Diabetes Care 47, 1584-1592 (2024)
Emmert-Fees, K. et al. Cost-effectiveness of a collaborative care model among patients with type 2 diabetes and depression in India. Diabetes Care 46, 11-19 (2023)
Frohnert, B.I.* et al. Refining the definition of stage 1itype 1 diabetes: An ontology-driven analysis of the heterogeneity of multiple Islet autoimmunity. Diabetes Care 46, 1753-1761 (2023)
Liu, X.* et al. Physical activity and the development of islet autoimmunity and type 1 diabetes in 5-to 15-year-old children followed in the TEDDY study. Diabetes Care 46, 1409-1416 (2023)
Lönnrot, M.* et al. Gastrointestinal infections modulate the risk for insulin autoantibodies as the first-appearing autoantibody in the TEDDY Study. Diabetes Care 46, 1908-1915 (2023)
Ott, R. et al. Epigenome-wide meta-analysis reveals associations between dietary glycemic index and glycemic load and DNA methylation in children and adolescents of different body sizes. Diabetes Care 46, 2067-2075 (2023)
Russell, W.E.* et al. Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: A randomized, double-masked, controlled trial. Diabetes Care 46, 1005-1013 (2023)
Thorsen, S.U.* et al. Interaction between dietary iron intake and genetically determined iron overload: Risk of islet autoimmunity and progression to Type 1 diabetes in the TEDDY study. Diabetes Care 46, 1014-1018 (2023)
Uusitalo, U.* et al. HLA genotype and probiotics modify the association between timing of solid food introduction and islet autoimmunity in the TEDDY Study. Diabetes Care 46, 1839-1847 (2023)
Aslam. A.A.* et al. Diabetes and obesity in down syndrome across the lifespan: A retrospective cohort study using U.K. electronic health records. Diabetes Care 45, 2892–2899 (2022)
Auzanneau, M.* et al. Frequency of ketoacidosis at diagnosis of pediatric type 1 diabetes associated with socioeconomic deprivation and Uubanization: Results from the German Multicenter DPV Registry. Diabetes Care 45, 1807-1813 (2022)
Heianza, Y.* et al. Changes in circulating miR-375-3p and improvements in visceral and hepatic fat contents in response to lifestyle interventions: The CENTRAL trial. Diabetes Care 45, 1911-1913 (2022)
Jacobsen, L.M.* et al. Heterogeneity of DKA incidence and age-specific clinical characteristics in children diagnosed with type 1 diabetes in the TEDDY Study. Diabetes Care 45, 624-633 (2022)
Karl, F. ; Winkler, C. ; Ziegler, A.-G. ; Laxy, M. & Achenbach, P. Costs of public health screening of children for presymptomatic type 1 diabetes in Bavaria, Germany. Diabetes Care 45, 837-844 (2022)
Krischer, J.P.* et al. Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: The TEDDY study. Diabetes Care 45, 2271-2281 (2022)
Kullmann, S. et al. Empagliflozin improves insulin sensitivity of the hypothalamus in humans with prediabetes: A randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes Care 45, 398-406 (2022)
Küpers, L.K.* et al. Maternal dietary glycemic index and glycemic load in pregnancy and offspring cord blood DNA methylation. Diabetes Care 45, 1822-1832 (2022)
Ng, K.* et al. Islet autoantibody type-specific titer thresholds improve stratification of risk of progression to type 1 diabetes in children. Diabetes Care 45, 160-168 (2022)
Rossing, P.* et al. Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium-glucose cotransporter 2 inhibitor treatment: The FIDELITY analysis. Diabetes Care 45, 2991–2998 (2022)
Schlögl, H. & Stumvoll, M.* The brains behind SGLT2 inhibition. Diabetes Care 45, 273-275 (2022)
Tobi, E.W.* et al. Maternal glycemic dysregulation during pregnancy and neonatal blood DNA methylation: Meta-analyses of epigenome-wide association studies. Diabetes Care 45, 614-623 (2022)
Vehik, K.* et al. Rising hemoglobin A1c in the nondiabetic range predicts progression of type 1 diabetes as well as oral glucose tolerance tests. Diabetes Care 45, 2342-2349 (2022)
Ahuja, V.* et al. Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults: A meta-analysis. Diabetes Care 44, 1062-1069 (2021)
Anand, V.* et al. Islet autoimmunity and HLA markers of presymptomatic and clinical type 1 diabetes: Joint analyses of prospective cohort studies in Finland, Germany, Sweden, and the U.S. Diabetes Care 44, 2269-2276 (2021)
Bizzotto, R.* et al. Processes underlying glycemic deterioration in type 2 diabetes: An IMI DIRECT Study. Diabetes Care 44, 511-518 (2021)
Blonde, L.* et al. Durable effects of iGlarLixi up to 52 weeks in type 2 diabetes: The LixiLan-G Extension Study. Diabetes Care 44, 774-780 (2021)
Bonifacio, E. et al. An age-related exponential decline in the risk of multiple islet autoantibody seroconversion during childhood. Diabetes Care 44, 2260-2268 (2021)
Canouil, M.* et al. Epigenome-wide association study reveals methylation loci associated with offspring gestational diabetes mellitus exposure and maternal methylome. Diabetes Care 44, 1992-1999 (2021)
Neuwahl, S.J.* et al. Patient health utility equations for a type 2 diabetes model. Diabetes Care 44, 381-389 (2021)
Pedron, S. ; Kurz, C.F. ; Schwettmann, L. & Laxy, M. The effect of BMI and type 2 diabetes on socioeconomic status: A two-sample multivariable mendelian randomization study. Diabetes Care 44, 850-852 (2021)
Shao, H.* et al. Trends in total and out-of-pocket payments for noninsulin glucose-lowering drugs among U.S. adults with large-employer private health insurance from 2005 to 2018. Diabetes Care 44, 925-934 (2021)
Shao, H. et al. Trends in total and out-of-pocket payments for insulin among privately insured U.S. adults with diabetes from 2005 to 2018. Diabetes Care 44, e1-e3 (2021)
Sujana, C. et al. Natriuretic peptides and risk of type 2 diabetes: Results from the biomarkers for cardiovascular risk assessment in Europe (BiomarCaRE) consortium. Diabetes Care 44, 2527-2535 (2021)
Addala, A.* et al. A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: A transatlantic comparison. Diabetes Care 44, 133-140 (2020)
Garvey, W.T.* et al. Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial. Diabetes Care 43, 1085-1093 (2020)
Kahl, S.* et al. Empagliflozin effectively lowers liver fat content in well-controlled Type 2 Diabetes: A randomized, double-blind, phase 4, placebo-controlled trial. Diabetes Care 43, 298-305 (2020)
Liu, X.* et al. Distinct growth phases in early life associated with the risk of type 1 diabetes: The TEDDY study. Diabetes Care 43, 556-562 (2020)
Ochoa-Rosales, C.* et al. Epigenetic link between statin therapy and type 2 diabetes. Diabetes Care 43, 875-884 (2020)
Soldo, J.* et al. Increased hepatic ACE2 expression in NAFL and diabetes-A risk for COVID-19 patients? Diabetes Care 43, E134-E136 (2020)
Vehik, K.* et al. Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the Teddy study. Diabetes Care 43, 2066-2073 (2020)
Dawed, A.Y.* et al. Variation in the plasma membrane monoamine transporter (PMAT, encoded in SLC29A4) and organic cation transporter 1 (OCT1, encoded in SLC22A1) and gastrointestinal intolerance to metformin in type 2 diabetes: An IMI DIRECT study. Diabetes Care 42, 1027-1033 (2019)
Hulman, A.* et al. Glucose measurements at various time points during the OGTT and their role in capturing glucose response patterns. Diabetes Care 42, e56-e57 (2019)
Kowall, B.* et al. Incidence rates of type 2 diabetes in people with impaired fasting glucose (ADA vs. WHO Criteria) and impaired glucose tolerance: Results from an older population (KORA S4/F4/FF4 Study). Diabetes Care 42, E18-E20:DC181473 (2019)
Krischer, J.P.* et al. Predicting islet cell autoimmunity and type 1 diabetes: An 8-year TEDDY study progress report. Diabetes Care 42, 1051-1060 (2019)
Schlesinger, S.* et al. General and abdominal obesity and incident distal sensorimotor polyneuropathy: Insights into inflammatory biomarkers as potential mediators in the KORA F4/FF4 cohort. Diabetes Care 42, 240-247 (2019)
Winkler, C. et al. Age, HLA, and sex define a marked risk of organ-specific autoimmunity in first-degree relatives of patients with type 1 diabetes. Diabetes Care 42, 1684-1691 (2019)
Andersen, S.T.* et al. Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: Addition-Denmark. Diabetes Care 41, 1068-1075 (2018)
Auzanneau, M.* et al. Area deprivation and regional disparities in treatment and outcome quality of 29,284 pediatric patients with type 1 diabetes in Germany: A cross-sectional multicenter DPV analysis. Diabetes Care 41, 2517-2525 (2018)
Frank-Podlech, S. et al. Leptin replacement reestablishes brain insulin action in the hypothalamus in congenital leptin deficiency. Diabetes Care 41, 907-910 (2018)
Kähm, K. et al. Health care costs associated with incident complications in patients with type 2 diabetes in Germany. Diabetes Care 41, 971-978 (2018)
Uusitalo, U.* et al. Early infant diet and islet autoimmunity in the TEDDY Study. Diabetes Care 41, 522-530 (2018)
Herder, C.* et al. Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4/FF4 Study. Diabetes Care 40, 569-576 (2017)
TEDDY Study Group (Hummel, S. ; Beyerlein, A. ; Ziegler, A.-G.) et al. First infant formula type and risk of islet autoimmunity in the environmental determinants of diabetes in the young (TEDDY) study. Diabetes Care 40, 398-404 (2017)
Johnson, S.B.* ; Lynch, K.F.* ; TEDDY Study Group (Roth, R.) & Schatz, D.* My child is islet autoantibody positive: Impact on parental anxiety. Diabetes Care 40, 1167-1172 (2017)
Kollerits, B.* et al. Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes: A pooled analysis in more than 20,000 individuals. Diabetes Care 40, 1386-1393 (2017)
Krischer, J.P.* et al. Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: The TEDDY Study. Diabetes Care 40, 1194-1202 (2017)
Frank, S.* et al. Neuronal food reward activity in patients with type 2 diabetes with improved glycemic control after bariatric surgery. Diabetes Care 39, 1311-1317 (2016)
Jordan, J.* ; El-Armouche, A.* ; Hanefeld, M.* ; Bornstein, S.R. & Birkenfeld, A.L. CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114. Diabetes Care 39, E224-E225 (2016)
Vehik, K.* et al. Reversion of β-cell autoimmunity changes risk of type 1 diabetes: TEDDY study. Diabetes Care 39, 1535-1542 (2016)
Bonifacio, E. Predicting type 1 diabetes using biomarkers. Diabetes Care 38, 989-996 (2015)
Brandmaier, S. et al. Response to Comment on Xu et al. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care 2015;38:1858-1867. Diabetes Care 38, e216-e217 (2015)
Herder, C.* et al. Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: Results from the KORA F4 study. Diabetes Care 38, 91-96 (2015)
Insel, R.A.* et al. Staging presymptomatic type 1 diabetes: A scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38, 1964-1974 (2015)
Kemppainen, K.M.* et al. Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes. Diabetes Care 38, 329-332 (2015)
Kullmann, S. et al. Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults. Diabetes Care 38, 1044-1050 (2015)
Shariful Islam, S.M.* et al. Effects of mobile phone SMS to improve glycemic control among patients with type 2 diabetes in Bangladesh: A prospective, parallel-group, randomized controlled trial. Diabetes Care 38, e112-e113 (2015)
Steck, A.K.* et al. Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care 38, 808-813 (2015)
Xu, T. et al. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care 38, 1858-1867 (2015)
Beyerlein, A. et al. Timing of gluten introduction and islet autoimmunity in young children: Updated results from the BABYDIET study. Diabetes Care 37, e194-e195 (2014)
Krause, S. et al. GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial. Diabetes Care 37, 1675-1680 (2014)
Laxy, M. et al. The association between patient-reported self-management behavior, intermediate clinical outcomes, and mortality in patients with type 2 diabetes: Results from the KORA-A study. Diabetes Care 37, 1604-1612 (2014)
Smith, L.B.* et al. Factors associated with maternal-reported actions to prevent type 1 diabetes in the first year of the TEDDY study. Diabetes Care 37, 325-331 (2014)
Stefan, N. ; Peter, A. & Häring, H.-U. Comment on Hedderson et al. Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus. Diabetes Care 2014;37:1296-1303. Diabetes Care 37, e278-279 (2014)
Bongaerts, B.W.* et al. Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: The KORA F4 study. Diabetes Care 36, 1141-1146 (2013)
Herder, C.* et al. Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study. Diabetes Care 36, 3663-3870 (2013)
Icks, A.* et al. Drug costs in prediabetes and undetected diabetes compared with diagnosed diabetes and normal glucose tolerance: Results from the population-based KORA survey in Germany. Diabetes Care 36, 53-54 (2013)
Lehmann, R.* et al. Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care 36, 2331-2338 (2013)
Marzi, C. et al. Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study. Diabetes Care 36, 1321-1326 (2013)
Bongaerts, B.W.C.* et al. Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: The KORA F4 study. Diabetes Care 35, 1891-1893 (2012)
de Miguel-Yanes, J.M.* et al. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 34, 121-125 (2011)
Hummel, S. ; Pflüger, M. ; Hummel, M. ; Bonifacio, E.* & Ziegler, A.-G. Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: The BABYDIET study. Diabetes Care 34, 1301-1305 (2011)
Meisinger, C. et al. Retinol-binding protein 4 is associated with prediabetes in adults from the general population: The Cooperative Health Research in the Region of Augsburg (KORA) F4 Study. Diabetes Care 34, 1648-1650 (2011)
Schlosser, M.* et al. Diabetes antibody standardization program: First evaluation of assays for autoantibodies to IA-2β. Diabetes Care 34, 2410-2412 (2011)
Thorand, B. et al. Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: Results from the MONICA/KORA Augsburg study. Diabetes Care 34, 2320-2322 (2011)
Boerschmann, H.* ; Pflüger, M. ; Henneberger, L. ; Ziegler, A.-G. & Hummel, S. Prevalence and predictors of overweight and insulin resistance in offspring of mothers with gestational diabetes mellitus. Diabetes Care 33, 1845-1849 (2010)
Hahn, V. et al. Physical activity and the metabolic syndrome in elderly German men and women: Results from the population-based KORA survey. Diabetes Care 32, 511-513 (2009)
Herder, C.* et al. Transforming growth factor-β1 and incident type 2 diabetes: Results from the MONICA/KORA case-cohort study, 1984-2002. Diabetes Care 32, 1921-1923 (2009)
Herder, C.* et al. Subclinical inflammation and diabetic polyneuropathy. Diabetes Care 32, 680-682 (2009)
Brandstatter, A.* et al. Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care 31, 1662-1667 (2008)
Ziegler, D.* ; Rathmann, W.* ; Dickhaus, T.* ; Mielck, A. & KORA Study Group (Meisinger, C. ; Wichmann, H.-E. ; Holle, R. ; John, J. ; Illig, T. ; Peters, A.) Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: The MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 31, 464-469 (2008)
Ziegler, D.* et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: The MONICA/KORA Augsburg Cohort Study. Diabetes Care 31, 556-561 (2008)
Kuch, B.* et al. Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: The Augsburg Diabetes Family Study. Diabetes Care 30, 946-952 (2007)
Thorand, B. et al. Sex differences in the prediction of type 2 diabetes by inflammatory markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 30, 854-860 (2007)
Herder, C.* et al. Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29, 368-371 (2006)
Herder, C.* et al. Hypoadiponectinemia and proinflammatory state: Two sides of the same coin? Diabetes Care 29, 1626-1631 (2006)
Herder, C.* et al. Circulating levels of interleukin-18 independent of body fat and fat-free mass: Results from the MONICA/KORA study. Diabetes Care 29, 174-175 (2006)
Kollerits, B.* et al. Lipoprotein(a) as a predictor of cardiovascular disease in a prospectively followed cohort of patients with type 1 diabetes. Diabetes Care 29, 1661-1663 (2006)
Rathmann, W. et al. Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO and NCEP definitions and associations with C-reactive protein. The KORA Survey 2000. Diabetes Care 29, S. 461 (2006)
Icks, A.* et al. Cost-effectiveness analysis of different screening procedures for type 2 diabetes. Diabetes Care 27, 2120-2128 (2005)
Meisinger, C. ; Heier, M. ; Döring, A. ; Thorand, B. & Löwel, H. Prevalence of known diabetes and antidiabetic therapy between 1984/1985 and 1999/2001 in Southern Germany. Diabetes Care 27, 2985-2987 (2005)
Liesenfeld, B.* et al. A telemedical approach to the screening of diabetic retinopathy: Digital fundus photography. Diabetes Care 23, 345-348 (2000)